Skip to main content
Livermore
Livermore
ZHEN

Intra-Cellular Therapies, Inc.

ITCIDelisted Apr 2, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001567514

Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.

Q3 2024 vs. Q2 2024

How the institutions holding Intra-Cellular Therapies, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of ITCI: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders3763356−17
Shares96.6M6.34M97.2M+6.89M (+7.6%)
Value$6.62B$434.1M$7.12B+$937.9M (+15.2%)

3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (45)

Institutions that held Intra-Cellular Therapies, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to ITCI in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.6,219,077$455.0M0.01%
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.404,656$29.6M4.11%
Candriam Luxembourg S.C.A.164,132$12.0M0.07%
Eversept Partners, LP124,491$9.11M0.70%
M&G Plc124,324$9.08M0.05%
Edgestream Partners, L.P.54,629$4.00M0.18%
Bank of Nova Scotia49,000$3.59M0.01%
Twinbeech Capital LP45,807$3.35M0.06%
B. Metzler seel. Sohn & Co. Holding AG33,291$2.44M0.02%
Vestal Point Capital, LP30,000$2.20M0.17%
Capital Fund Management S.A.26,093$1.91M0.02%
Two Sigma Investments, LP23,490$1.72M0.00%
Connor, Clark & Lunn Investment Management Ltd.17,099$1.25M0.01%
Savant Capital, LLC13,928$1.02M0.01%
ADAR1 Capital Management, LLC13,400$980.5K0.16%
Entropy Technologies, LP7,116$520.7K0.05%
Lecap Asset Management Ltd6,815$498.7K0.11%
Ieq Capital, LLC5,690$416.3K0.01%
Allianz Asset Management GmbH5,000$365.9K0.00%
Raymond James Financial Services Advisors, Inc.4,197$307.1K0.00%
nVerses Capital, LLC3,900$285.4K0.13%
Jones Financial Companies LLLP3,840$281.5K0.00%
HighTower Advisors, LLC3,829$280.0K0.00%
MQS Management LLC3,672$268.7K0.15%
Colony Group, LLC3,563$260.7K0.00%
Versor Investments LP3,509$256.8K0.04%
Whalen Wealth Management Inc.2,996$219.2K0.16%
Amundi2,935$212.5K0.00%
CIBC Asset Management Inc2,806$205.3K0.00%
IFP Advisors, Inc2,429$177.7K0.01%
Acadian Asset Management LLC2,056$150.0K0.00%
Sterling Capital Management LLC1,870$136.8K0.00%
Danske Bank A/S1,400$102.4K0.00%
Bryn Mawr Trust Co1,329$97.2K0.00%
Capital Performance Advisors LLP1,012$74.0K0.02%
True Wealth Design, LLC434$31.8K0.01%
Ashton Thomas Securities, LLC172$12.6K0.00%
Truvestments Capital LLC89$6.51K0.00%
Geneos Wealth Management Inc.84$6.15K0.00%
Wolff Wiese Magana LLC32$2.34K0.00%
Rakuten Securities, Inc.15$1.10K0.00%
Montag A & Associates Inc13$9570.00%
Fifth Third Bancorp10$7320.00%
Voisard Asset Management Group, Inc.7$5130.00%
Riverview Trust Co7$5120.00%

Sold out (62)

Institutions that held Intra-Cellular Therapies, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of ITCI in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Balyasny Asset Management LLC406,714$27.9M
Integral Health Asset Management, LLC145,000$9.93M
Citadel Advisors LLC133,673$9.16M
Paloma Partners Management Co70,040$4.80M
Mirae Asset Global ETFs Holdings Ltd.50,437$3.45M
Ghisallo Capital Management LLC50,000$3.42M
Alpine Global Management, LLC35,300$2.42M
Scientech Research LLC35,270$2.42M
PDT Partners, LLC35,218$2.41M
Moore Capital Management, LP25,000$1.71M
Virtu Financial LLC20,738$1.42M
Point72 (DIFC) Ltd20,385$1.40M
XTX Topco Ltd20,220$1.38M
Fox Run Management, L.L.C.18,575$1.27M
Jefferies Financial Group Inc.17,000$1.16M
Fred Alger Management, LLC16,564$1.13M
HSBC Holdings PLC13,986$958.1K
Inceptionr LLC12,055$825.6K
Campbell & CO Investment Adviser LLC11,737$803.9K
Dynamic Technology Lab Private Ltd10,947$750.0K
Verition Fund Management LLC10,364$709.8K
Teachers Retirement System of the State of Kentucky10,298$705.0K
Ghost Tree Capital, LLC10,000$684.9K
Mirabella Financial Services LLP9,630$659.6K
Laurion Capital Management LP9,270$634.9K
OmniStar Financial Group, Inc.9,242$633.0K
Sherbrooke Park Advisers LLC6,833$468.0K
Mackenzie Financial Corp4,919$336.9K
Crossmark Global Holdings, Inc.4,652$319.0K
Omers Administration Corp4,500$308.2K
AlphaMark Advisors, LLC4,219$289.0K
Pearl River Capital, LLC4,047$277.2K
Systematic Portfolios LLC3,973$272.1K
Arrowstreet Capital, Limited Partnership3,906$268.0K
Catalyst Funds Management Pty Ltd3,900$267.1K
Quantbot Technologies LP3,782$259.0K
O'Shaughnessy Asset Management, LLC3,674$251.6K
Gsa Capital Partners LLP3,668$251.0K
Central Pacific Bank - Trust Division3,645$249.6K
Teza Capital Management LLC3,417$234.0K
Diametric Capital, LP3,077$210.7K
Nomura Holdings Inc3,005$205.8K
Walleye Trading LLC1,339$91.7K
EntryPoint Capital, LLC1,268$86.8K
Allianz SE850$58.2K
Clear Street Markets LLC816$56.0K
Caption Management, LLC618$42.3K
Annis Gardner Whiting Capital Advisors, LLC262$17.9K
Bessemer Group Inc115$8.00K
Front Row Advisors LLC97$6.64K
Exchange Traded Concepts, LLC93$6.37K
Hillsdale Investment Management Inc.90$6.16K
Mather Group, LLC.75$5.19K
Itau Unibanco Holding S.A.50$3.42K
Meeder Asset Management Inc47$3.22K
Valley National Advisers Inc50$3.00K
Cohen & Steers, Inc.42$3.00K
Innealta Capital, LLC36$2.47K
Stephens Consulting, LLC32$2.19K
Rothschild Investment LLC30$2.06K
CIBC Private Wealth Group, LLC25$1.79K
International Assets Investment Management, LLC12$822

Not filed for Q3 2024 yet (3)

Institutions that held Intra-Cellular Therapies, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ITCI in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.6,321,619$433.0M
Susquehanna Fundamental Investments, LLC17,108$1.17M
Institutional & Family Asset Management, LLC15$1.03K